
Photon-Counting CT Improves Image Quality and Cuts Radiation Dose in Myeloma
A retrospective comparative study shows photon-counting computed tomography delivers higher image quality and reduced radiation doses in multiple myeloma patients.
mielomamultiplo.com · Multiple Myeloma

A retrospective comparative study shows photon-counting computed tomography delivers higher image quality and reduced radiation doses in multiple myeloma patients.
In the last 24 hours, several news items related to multiple myeloma have been released. In the US, the National Institutes of Health (NIH) shared data from the early stages of a treatment combining a bispecific antibody targeting BCMA for relapsed/refractory multiple myeloma. In Brazil, the state of Tocantins incorporated a high-cost medication into the treatment of this disease. In the US, a grant from Pfizer for multiple myeloma education was also announced. Furthermore, a retrospective study in the United States demonstrated that Photon-Counting Computed Tomography (CT) improves image quality and reduces radiation dose in patients with multiple myeloma. Another news item, with an unidentified origin, refers to a list of the 10 most important abstracts to be presented at ASH 2026, focusing on therapies such as CAR-T and Daratumumab. Additionally, Tempest Therapeutics acquired the rights to develop and commercialize an experimental treatment for multiple myeloma. Finally, a publication in the UK discussed the targeting of the NFIL3-MYC axis inhibition as a way to overcome therapy resistance in high-risk multiple myeloma.
Made by MielomaAI As of November 17, 2026, 3:22 PM. May contain errors: view the news and speak with your doctor.













A retrospective comparative study shows photon-counting computed tomography delivers higher image quality and reduced radiation doses in multiple myeloma patients.
Cobertura jornalística abrangente e atualizada, reunida a partir de fontes em todo o mundo pelo Google News.



'MRD is becoming a very valuable tool, but it's not an exclusive tool,' says expert

November 16 2026 Multiple myeloma treatment is expanding across antibody combinations CAR T cell therapies and newer immune modifying drugs Recent U S approvals have brought some options into earlier treatment lines while new subcutaneous formulations are changing how antibody ...

Tempest Therapeutics has exercised an option to obtain rights to develop and commercialize an experimental treatment for myeloma.


The first administration of daratumumab was performed on a patient with multiple myeloma attended at the HGP.
Etentamig in Relapsed/Refractory Multiple Myeloma: Pooled Phase 1 Data of an Investigational BCMA Bispecific Antibody
Hi everyone, Recently my dad got diagnosed with myeloma. My dad and the rest of my family live in New Zealand and I live in Canada. I’ll be completing the Ironman in Ottawa 2027 to raise awareness for treatment for Myeloma. I’ll be documenting the training
Tocantins incorporates high-cost medication into the treatment of multiple myeloma.
For people with blood cancer, survivors, family members and carers: the multi-purpose disability certificate, social support, work, taxes, carers and the Right to be Forgotten.
From the Portuguese League Against Cancer: national health service, social security, tax benefits, work, credit and insurance, and the specific rules of the Azores and Madeira.
Sources: APCL — Portuguese Association Against Leukaemia, and LPCC — Portuguese League Against Cancer. MielomaAI's answers are based only on these two guides and do not replace the hospital social worker.
The symbol brings together two stories: that of the macedotuga.com, from Vila do Conde, and that of multiple myeloma.
It is always better to be an informed patient. There is hope. There is a way forward.